SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0000950123-00-001903
Filing Date
2000-03-03
Accepted
2000-03-03 00:00:00
Documents
3
Effectiveness Date
2000-03-03

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO. 1 TO S-8 S-8 POS 61032
2 OPINION OF SAUL, EWING, REMICK & SAUL LLP EX-5 2765
3 CONSENT OF KPMG LLP EX-23.1 473
  Complete submission text file 0000950123-00-001903.txt   66035
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: S-8 POS | Act: 33 | File No.: 333-39509 | Film No.: 560314
SIC: 2835 In Vitro & In Vivo Diagnostic Substances